Chronic Hepatitis B Infection: Long Term Comparison of Children Receiving Interferon Alpha and Untreated Controls

Abstract

These findings show that the overall long-term virological outcome does not differ significantly between IFN-treated and untreated children but that a significant benefit of treatment on the long term rate of HBeAg seroconversion is obtained in children with higher baseline ALT levels.